Found 0 matching trials
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy PHASE2 This study is a multicenter, prospective, randomized phase II trial aimed a...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Combination Study of CAR-T Therapy in r/r B-NHL PHASE2 In registry studies of CAR-T products that have been marketed globally, pat...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs PHASE2 The goal of this prospective study is to explore the safety and preliminary...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCI EARLY_PHASE1 The purpose of this study is to assess the safety and tolerability of intra...
Show More Location
The University of Chicago
Learn More & Join Trial
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer NA This clinical trial studies fludarabine phosphate, low-dose total body irra...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD PHASE2 Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Show More Location
Hospital Maissoneuve
Learn More & Join Trial
Resection And Partial Liver Segmental Transplantation With Delayed Total Hepatectomy NA RAPID is an auxiliary liver transplantation where a small liver partial gra...
Show More Location
U.O.C Chirurgia Epatobiliare e Trapianti Epatici, Azienda Ospedaliera di Padova
Learn More & Join Trial
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome PHASE2 RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Show More Learn More & Join Trial
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC PHASE1 The first testing of TargomiRs in the human setting: dose-finding studies i...
Show More Location
Concord Repatriation General Hospital
Learn More & Join Trial
PRO#0118: Decitabine Plus Mini Flu-Bu PHASE1 This is a single institution study of combining decitabine with fludarabine...
Show More Location
Hackensack University Medical Center - John Theurer Cancer Center
Learn More & Join Trial